1. Home
  2. PCLA vs ABP Comparison

PCLA vs ABP Comparison

Compare PCLA & ABP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PicoCELA Inc. American Depositary Shares

PCLA

PicoCELA Inc. American Depositary Shares

HOLD

Current Price

$0.21

Market Cap

18.6M

ML Signal

HOLD

ABP

Abpro Holdings Inc

HOLD

Current Price

$5.77

Market Cap

18.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCLA
ABP
Founded
2008
2004
Country
Japan
United States
Employees
N/A
N/A
Industry
Building Products
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.6M
18.8M
IPO Year
2025
N/A

Fundamental Metrics

Financial Performance
Metric
PCLA
ABP
Price
$0.21
$5.77
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
748.5K
28.9K
Earning Date
01-01-0001
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,065,197.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
5.26
50.00
52 Week Low
$0.25
$4.55
52 Week High
$9.80
$153.90

Technical Indicators

Market Signals
Indicator
PCLA
ABP
Relative Strength Index (RSI) 19.99 55.40
Support Level $0.27 $5.55
Resistance Level $0.33 $6.38
Average True Range (ATR) 0.02 0.55
MACD -0.00 -0.26
Stochastic Oscillator 7.00 32.25

Price Performance

Historical Comparison
PCLA
ABP

About PCLA PicoCELA Inc. American Depositary Shares

PicoCELA Inc specializes in manufacturing, installing, and servicing enterprise wireless mesh solutions. The company generates revenue from two main sources: product equipment sales, and Software as a Service (SaaS) and maintenance services. The company develops the PCWL series of mesh Wi-Fi access points, which utilize its proprietary PicoCELA Backhaul Engine (PBE) technology to enable wireless communication. The company outsources manufacturing and sells these devices directly to customers through distributors. Additionally, the company offers a cloud portal service in a SaaS model, allowing users to monitor connectivity and traffic at their access points. This platform also supports the installation of proprietary edge-computing software into the devices.

About ABP Abpro Holdings Inc

Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.

Share on Social Networks: